100 related articles for article (PubMed ID: 20387637)
1. Screening of epigenetic and genetic disturbances of human chromosome 3 genes in colorectal cancer.
Gerashchenko GV; Gordiyuk VV; Skrypkina IY; Kvasha SM; Kolesnik OO; Ugryn DD; Pavlova TV; Zabarovsky ER; Rynditch AV; Kashuba VI
Ukr Biokhim Zh (1999); 2009; 81(4):81-7. PubMed ID: 20387637
[TBL] [Abstract][Full Text] [Related]
2. [Technology of analysis of epigenetic and structural changes of epithelial tumors genome with NotI-microarrays by the example of human chromosome].
Pavlova TV; Kashuba VI; Muravenko OV; Yenamandra SP; Ivanova TA; Zabarovskaia VI; Rakhmanaliev ER; Petrenko LA; Pronina IV; Loginov VI; Iurkevich OIu; Kiselev LL; Zelenin AV; Zabarovskiĭ ER
Mol Biol (Mosk); 2009; 43(2):339-47. PubMed ID: 19425501
[TBL] [Abstract][Full Text] [Related]
3. Genetic and epigenetic analysis of non-small cell lung cancer with NotI-microarrays.
Dmitriev AA; Kashuba VI; Haraldson K; Senchenko VN; Pavlova TV; Kudryavtseva AV; Anedchenko EA; Krasnov GS; Pronina IV; Loginov VI; Kondratieva TT; Kazubskaya TP; Braga EA; Yenamandra SP; Ignatjev I; Ernberg I; Klein G; Lerman MI; Zabarovsky ER
Epigenetics; 2012 May; 7(5):502-13. PubMed ID: 22491060
[TBL] [Abstract][Full Text] [Related]
4. [Identification of changes in gene loci potentially associated with cervical cancer using NotI microarrays].
Kashuba VI; Skripkina IIa; Saraev DV; Gordiiuk VV; Vinnitskaia AB; Tsyba LA; Pogrebnoĭ PV; Blinov VM; Zabarovskiĭ ER; Ryndich AV
Ukr Biokhim Zh (1999); 2006; 78(2):113-20. PubMed ID: 17100293
[TBL] [Abstract][Full Text] [Related]
5. Novel tumor suppressor candidates on chromosome 3 revealed by NotI-microarrays in cervical cancer.
Senchenko VN; Kisseljova NP; Ivanova TA; Dmitriev AA; Krasnov GS; Kudryavtseva AV; Panasenko GV; Tsitrin EB; Lerman MI; Kisseljov FL; Kashuba VI; Zabarovsky ER
Epigenetics; 2013 Apr; 8(4):409-20. PubMed ID: 23478628
[TBL] [Abstract][Full Text] [Related]
6. Use of DNA from human stools to detect aberrant CpG island methylation of genes implicated in colorectal cancer.
Belshaw NJ; Elliott GO; Williams EA; Bradburn DM; Mills SJ; Mathers JC; Johnson IT
Cancer Epidemiol Biomarkers Prev; 2004 Sep; 13(9):1495-501. PubMed ID: 15342451
[TBL] [Abstract][Full Text] [Related]
7. Identification of GABRA1 and LAMA2 as new DNA methylation markers in colorectal cancer.
Lee S; Oh T; Chung H; Rha S; Kim C; Moon Y; Hoehn BD; Jeong D; Lee S; Kim N; Park C; Yoo M; An S
Int J Oncol; 2012 Mar; 40(3):889-98. PubMed ID: 22038115
[TBL] [Abstract][Full Text] [Related]
8. Beyond the island: epigenetic biomarkers of colorectal and prostate cancer.
Savio AJ; Bapat B
Methods Mol Biol; 2015; 1238():103-24. PubMed ID: 25421657
[TBL] [Abstract][Full Text] [Related]
9. Identification of diagnostic markers in colorectal cancer via integrative epigenomics and genomics data.
Kok-Sin T; Mokhtar NM; Ali Hassan NZ; Sagap I; Mohamed Rose I; Harun R; Jamal R
Oncol Rep; 2015 Jul; 34(1):22-32. PubMed ID: 25997610
[TBL] [Abstract][Full Text] [Related]
10. Intermediate- and low-methylation epigenotypes do not correspond to CpG island methylator phenotype (low and -zero) in colorectal cancer.
Karpinski P; Walter M; Szmida E; Ramsey D; Misiak B; Kozlowska J; Bebenek M; Grzebieniak Z; Blin N; Laczmanski L; Sasiadek MM
Cancer Epidemiol Biomarkers Prev; 2013 Feb; 22(2):201-8. PubMed ID: 23175427
[TBL] [Abstract][Full Text] [Related]
11. The CpG island methylator phenotype correlates with long-range epigenetic silencing in colorectal cancer.
Karpinski P; Ramsey D; Grzebieniak Z; Sasiadek MM; Blin N
Mol Cancer Res; 2008 Apr; 6(4):585-91. PubMed ID: 18403637
[TBL] [Abstract][Full Text] [Related]
12. Two histologically colorectal carcinomas subsets from the serrated pathway show different methylome signatures and diagnostic biomarkers.
García-Solano J; Turpin MC; Torres-Moreno D; Huertas-López F; Tuomisto A; Mäkinen MJ; Conesa A; Conesa-Zamora P
Clin Epigenetics; 2018 Nov; 10(1):141. PubMed ID: 30413173
[TBL] [Abstract][Full Text] [Related]
13. DNA methylation analysis using CpG microarrays is impaired in benzopyrene exposed cells.
Sadikovic B; Andrews J; Rodenhiser DI
Toxicol Appl Pharmacol; 2007 Dec; 225(3):300-9. PubMed ID: 17904174
[TBL] [Abstract][Full Text] [Related]
14. [Methylation in the Regulation of the Expression of Chromosome 3 and microRNA Genes in Clear-Cell Renal Cell Carcinomas].
Braga EA; Khodyrev DS; Loginov VI; Pronina IV; Senchenko VN; Dmitriev AA; Kubatiev AA; Kushlinskii NE
Genetika; 2015 Jun; 51(6):668-84. PubMed ID: 26310030
[TBL] [Abstract][Full Text] [Related]
15. The CpG island methylator phenotype and chromosomal instability are inversely correlated in sporadic colorectal cancer.
Goel A; Nagasaka T; Arnold CN; Inoue T; Hamilton C; Niedzwiecki D; Compton C; Mayer RJ; Goldberg R; Bertagnolli MM; Boland CR
Gastroenterology; 2007 Jan; 132(1):127-38. PubMed ID: 17087942
[TBL] [Abstract][Full Text] [Related]
16. Detection of CpG island hypermethylation of caspase-8 in neuroblastoma using an oligonucleotide array.
Kamimatsuse A; Matsuura K; Moriya S; Fukuba I; Yamaoka H; Fukuda E; Kamei N; Hiyama K; Sueda T; Hiyama E
Pediatr Blood Cancer; 2009 Jul; 52(7):777-83. PubMed ID: 19260109
[TBL] [Abstract][Full Text] [Related]
17. High throughput screening of methylation status of genes in prostate cancer using an oligonucleotide methylation array.
Yu YP; Paranjpe S; Nelson J; Finkelstein S; Ren B; Kokkinakis D; Michalopoulos G; Luo JH
Carcinogenesis; 2005 Feb; 26(2):471-9. PubMed ID: 15485992
[TBL] [Abstract][Full Text] [Related]
18. Epigenetic alterations of chromosome 3 revealed by NotI-microarrays in clear cell renal cell carcinoma.
Dmitriev AA; Rudenko EE; Kudryavtseva AV; Krasnov GS; Gordiyuk VV; Melnikova NV; Stakhovsky EO; Kononenko OA; Pavlova LS; Kondratieva TT; Alekseev BY; Braga EA; Senchenko VN; Kashuba VI
Biomed Res Int; 2014; 2014():735292. PubMed ID: 24977159
[TBL] [Abstract][Full Text] [Related]
19. A NotI-EcoRV promoter library for studies of genetic and epigenetic alterations in mouse models of human malignancies.
Yu L; Liu C; Bennett K; Wu YZ; Dai Z; Vandeusen J; Opavsky R; Raval A; Trikha P; Rodriguez B; Becknell B; Mao C; Lee S; Davuluri RV; Leone G; Van den Veyver IB; Caligiuri MA; Plass C
Genomics; 2004 Oct; 84(4):647-60. PubMed ID: 15475242
[TBL] [Abstract][Full Text] [Related]
20. Targeting aberrant chromatin structure in colorectal carcinomas.
Konishi K; Issa JP
Cancer J; 2007; 13(1):49-55. PubMed ID: 17464246
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]